Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-05 · accession 0001133416-25-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-11-07 | 2025-11-05 | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $6.00 | -600 | 7,614 | -7% | -$3,600 |
| DMT | 2025-11-07 | 2025-11-05 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $1.60 | +600 | 7,814 | +8% | +$962 |
| DMT | 2025-11-07 | 2025-11-05 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $0.00 | -600 | 52.8K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-11-05 | S | D | 200 | $6.00 | 7,614 | D | — | — | |
| 2 | Common | Common stock | 2025-11-05 | M | A | 200 | $1.98 | 7,814 | D | — | — | |
| 3 | Common | Common stock | 2025-11-05 | S | D | 200 | $6.00 | 7,614 | D | — | — | |
| 4 | Common | Common stock | 2025-11-05 | M | A | 200 | $1.11 | 7,814 | D | — | — | |
| 5 | Common | Common stock | 2025-11-05 | S | D | 200 | $6.00 | 7,614 | D | — | — | |
| 6 | Common | Common stock | 2025-11-05 | M | A | 200 | $1.72 | 7,814 | D | — | — | |
| 7 | Derivative | Stock option (right to buy) | 2025-11-05 | M | D | 200 | $0.00 | 39,566 | D | $1.11 · 2023-06-30 to 2034-01-26 | 200 Common stock | (F3) The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024. |
| 8 | Derivative | Stock option (right to buy) | 2025-11-05 | M | D | 200 | $0.00 | 39,586 | D | $1.98 · 0022-06-30 to 2032-01-24 | 200 Common stock | (F2) The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023. |
| 9 | Derivative | Stock option (right to buy) | 2025-11-05 | M | D | 200 | $0.00 | 52,809 | D | $1.72 · 2024-06-30 to 2034-01-22 | 200 Common stock | (F4) The options vested as follows: 25% on each of June 30, 2024, December 31, 2024, and June 30, 2025, with 25% scheduled to vest on December 31, 2025. |